Delivery Order SPE2DB24D1021-SPE2DB25FEZSX
Award Date 8/15/25
Potential Completion Date 8/18/25
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $13,544.96 delivery order to AmerisourceBergen Drug Corp for Konvomep 2-84 mg/mL oral suspension (300 mL) under a firm fixed price contract with an ultimate completion date of August 1, 2025. The award was made competitively with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents one transaction within the company's broader...
- This is a firm fixed price delivery order for $1,020.00 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order is for KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to provide a range of pharmaceutical products and medical...
- This federal contract award is a $10,169.84 Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product, with an ultimate completion date of July 11, 2025. This award is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery...
- This federal contract award, valued at $2,422.50, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and runs through December 2025. AmerisourceBergen, a major pharmaceutical distributor, will provide the government with 4565850019 ! KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (DO) valued at $2,912.78 issued by the Defense Logistics Agency (DLA). The award is for the pharmaceutical product KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, which is a medical supply for use by the U.S. government. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has an Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,616.87 Firm Fixed Price Delivery Order is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of October 6, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $41,480.40 to AmerisourceBergen Drug Corp on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation...
- The Defense Logistics Agency awarded a $2,335.98 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for pharmaceutical suspension products (4569113079 SPS 15 GM/60 ML Suspension 473ML). This firm fixed-price delivery order, with an ultimate completion date of August 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion and running through December 2026. The contract was...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $28,486.52 to AmerisourceBergen Drug Corp on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award represents a non-competitive set-aside...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $4,575.90 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle. The award was made through open competition with no set-aside...